Last Updated: 31-07-2025 | Format: PDF | Report ID:20263 | Author: Manisha C
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,950 Million |
| What is the projected market size by 2035? | $4,800 Million |
| What is the market CAGR from 2025 to 2035? | 9.4% |
| Which region dominates the market? | US (75%) |
| Which product/service type dominates the market? | Reagents & Kits (45%) |
| Which application leads the market? | Protein Purification (40%) |
| Who are the major buyers? | Pharmaceutical Companies (38%), Research & Academia (33%) |
| What are the key market growth drivers? | Growth in proteomics and genomics research is a major driver in 2025; Increased adoption of automation in sample preparation processes is accelerating market growth |
| What are the major market challenges? | Complexity of sample types and requirements for protocol standardization remain difficult; Cost constraints for small- and mid-sized labs limit widespread technology adoption |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| Thermo Fisher Scientific, Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Miltenyi Biotec, F. Hoffmann-La Roche Ltd, Claremont BioSolutions LLC, Promega Corporation, Agilent Technologies, Inc., PerkinElmer Inc., Beckman Coulter, Inc. (Danaher Corporation), Covaris, LLC, Norgen Biotek Corp., Others |
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Microcarriers Market: by Type (Microcarriers Beads, Magnetic Microcarriers, Collagen-based Microcarriers, Synthetic Polymer-based Microcarriers, DEAE-Dextran Based Microcarriers, Others), Application (Cell Therapy, Vaccine Manufacturing, Tissue Engineering, Biologics Production, Drug Development, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail Pharmacies, Specialty Stores, Others), Technology (Surface-modified Microcarriers, Porous Microcarriers, Biodegradable Microcarriers, Injectable Microcarriers, Composite Microcarriers, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025